Stock listing
NVAX Stock Price, News, Filings & Events — Novavax, Inc.
Selected listing: NVAX · VIE · EUR · AT
This page tracks Novavax, Inc.'s NVAX:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NVAX:VIE. NVAX:VIE is the stock-level entry point for investors researching Novavax, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Novavax, Inc. is a publicly traded company listed under the ticker NVAX, operating in the American market. The company has a market capitalization of approximately $1.35 billion. Novavax focuses on developing innovative vaccines to address various infectious diseases.
- Ticker
- NVAX:VIE
- Asset type
- Stock
- Market cap
- $1.53B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- VIE
- Currency
- EUR
Novavax, Inc. NVAX:VIE stock context
This page tracks Novavax, Inc.'s NVAX:VIE listing on VIE in EUR for AT, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NVAX:VIE. NVAX:VIE is the stock-level entry point for investors researching Novavax, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Novavax, Inc. is a publicly traded company listed under the ticker NVAX, operating in the American market. The company has a market capitalization of approximately $1.35 billion. Novavax focuses on developing innovative vaccines to address various infectious diseases.
Latest news from Novavax, Inc.
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccina...
August 28, 2026
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
July 30, 2026
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
June 1, 2026
Novavax to Participate in BofA Securities 2026 Health Care Conference
May 7, 2026
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
May 6, 2026
Novavax, Inc. earnings calls
Novavax, Inc. (NVAX) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Novavax, Inc. (NVAX) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Novavax, Inc. (NVAX) Q4 2025 Earnings Call
February 26, 2026 · Replay with transcript and chapters
Novavax, Inc. (NVAX) Q3 2025 Earnings Call
November 6, 2025 · Replay with transcript and chapters
Novavax, Inc. (NVAX) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Novavax, Inc. (NVAX) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Novavax, Inc.
Novavax, Inc. investor report
Review AI stock analysis and investor report context for NVAX:VIE.
Novavax, Inc. company profile
View the public company page for Novavax, Inc. on 6ix.
Novavax, Inc. news
Read company news and market updates connected to Novavax, Inc..
Novavax, Inc. investor events
Find investor webinars, events, and replay context for Novavax, Inc..
Alternate listings
NVAX:NASDAQ
US · USD
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
NVV1:GETTEX
DE · EUR
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
NVV1:TRADEGATE
DE · EUR
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
NVAX:BOATS
US · USD
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
A2PKMZ:LSX
DE · EUR
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
NVAX:BMV
MX · MXN
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
A2PKMZ:LS
DE · EUR
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
NVV1:FWB
DE · EUR
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
0A3S:LSIN
GB · USD
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
NVV1:DUS
DE · EUR
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
NVV1:SWB
DE · EUR
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.
NVAX:SIX
CH · CHF
Alternate listing for Novavax, Inc.; the primary context on this page is NVAX:VIE.